No, John, no -:)
Stocksmart's market cap information is historical. Better look at company releases, or EDGAR. I'm sure you did, because you quoted from them earlier.
Market capitalization is calculated by multiplying the number of shares outstanding by the current price, to indicate the current value of the company, as set by the market for its shares. On August 15, Agouron had 30,030,000 shares outstanding (split adjusted; not diluted). At $45 per share, where AGPH has been trading, $1.35 Billion is the minimum possible market cap (excludes in the money options issued.)
On 8/15/97, Vertex reported 25,096,445 shares outstanding on its 10-Q. At $35, a recent price, VRTX had a market cap of $878 mm. It has been over $1B for much of this year. VRTX has a deep and varied pipeline, as you know. A product which reverses multidrug resistance in cancer therapy has been the cornerstone of the company. Most of us understand Vertex, having read "The Billion Dollar Molecule", a book about the company which was a best seller.
John, you follow Agouron closely, though without much insight. I'm sure you know better than to pass on this incorrect information. You damage your stock when you tout so shamelessly -- we're investors, not Clueless Congress Critters -:) You don't need to lie to us; and you can't get away with it anyhow.
I still believe that AGPH will see $100 per share in the next three years.
Sources:
Agouron 10-K:
sec.gov
Vertex 10-Q
sec.gov |
